Instituto Rosenbusch S.A. (BCBA:ROSE)

Argentina · Delayed Price · Currency is ARS

156.00

-4.00 (-2.50%)

At close: Aug 14, 2026

Instituto Rosenbusch Financials Overview

Financials in millions ARS. Fiscal year is April - March.

Millions ARS. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	1,456	1,456	6,404	1,380	10,886	9,860
Revenue Growth	-77.02%	-77.27%	364.13%	-87.33%	10.40%	130.61%
Gross Profit	-332.06	-332.06	-286.03	-201.14	4,980	2,825
Operating Income	-1,188	-1,188	-3,369	-628.15	2,461	34.37
Net Income	-466.3	-466.3	-4,598	-782.47	-1,864	1,226
Earnings Per Share	-	-	-107.95	-	-43.78	28.78
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Biological Products	2,308
Pharmaceutical products	3,134
Other Items	165.11
Total	5,606

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	37.42	37.42	712.26	671.56	1,154	850.98
Total Debt	1,905	1,905	1,450	1,470	2,289	2,251
Net Cash (Debt)	-1,868	-1,868	-737.74	-798.71	-1,135	-1,400
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-	-	-17.32	-	-26.66	-32.88

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-1,862	-1,862	409.89	-299.46	720.31	331.37
Capital Expenditures	-28.25	-28.25	-12.13	-0.19	-13.65	-115.45
Free Cash Flow	-1,891	-1,891	397.75	-299.65	706.67	215.92
Free Cash Flow Growth	-	-	-	-	227.27%	205.25%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	-22.81%	-22.81%	-4.47%	-14.58%	45.75%	28.65%
Operating Margin	-81.61%	-81.61%	-52.61%	-45.53%	22.61%	0.35%
Pretax Margin	-32.03%	-32.03%	-69.70%	-56.71%	-17.15%	13.91%
Profit Margin	-32.03%	-32.03%	-71.80%	-56.71%	-17.13%	12.43%
FCF Margin	-129.88%	-129.88%	6.21%	-21.72%	6.49%	2.19%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 15, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
PE Ratio	-	-	-	-	-	2.22
P/FCF Ratio	16.70	-	25.75	-	7.35	12.62
PS Ratio	1.04	4.67	1.60	2.98	0.48	0.28